Metraipolis › archive › dc_b166b611a237

Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa — Europe PMC PMID:41405200

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41405200
DOI
10.1128/msystems.01384-25
License (as archived)
solo-consultazione
Archived
2026-11-08T14:16:45.347Z
SHA-256 of the archived text
98d2397ed2ca17600f58f833121d92023269e3ac5659a5643b0bbff25f4b2746
Stable URL of this page
https://metraipolis.com/documento/dc_b166b611a237

How to cite

Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa — Europe PMC PMID:41405200 — Europe PMC (en), https://europepmc.org/article/MED/41405200 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b166b611a237 (Metraipolis archive dc_b166b611a237, sha256 98d2397ed2ca17600f58f833121d92023269e3ac5659a5643b0bbff25f4b2746)
BibTeX
@misc{dcb166b611a237,
  title = {Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa — Europe PMC PMID:41405200},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41405200},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b166b611a237; sha256 98d2397ed2ca17600f58f833121d92023269e3ac5659a5643b0bbff25f4b2746},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41405200. Agents can read the archived copy with the MCP tool read_document.